primary IgA nephropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. age: 16 to 65 years old; 2. underwent renal biopsy within 1 year before start of trial; 3. 24 hour urinary protein excretion ranged between 1 to 7 g/d; 4. eGFR, evaluated by MDRD formula, should be higher than 30 ml/min.
Exclusion criteria
Exclusion criteria: 1. crescentic glomerulonephritis; 2. steroid therapy subjected within 1 year before trial; 3. malignant hypertension(DBP>130 mmHg and/or SBP>220mmHg), resistant to anti-hypertensive agents; 4. urinary protein excretion decrease below 1 g/l after run-in period; 5. Myocardial infarction or cerebrovascular accident in 6 months preceding the trial; 6. renovascular disease; 7. diabetes mellitus; 8. Malignancy, severe liver disease, refractory infection; 9. peptic ulcer in active disease phase; 10. pregnancy; 11. other contraindication to the use of ACEi/ ARB or corticosteroid; 12. alcohol abuse or drug addiction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hour urinary protein excretion;serum creatinine; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood pressure;urine routine analysis;Urea/BUN; | — |
Countries
China